Sabby Management, LLC Nrx Pharmaceuticals, Inc. Transaction History

Sabby Management, LLC

  • $1.52 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$0.23 - $0.5 $86,188 - $187,365
-374,731 Reduced 53.55%
325,000 $84,000
Q2 2023

Aug 14, 2023
BUY
$0.46 - $0.89 $321,876 - $622,760
699,731 New
699,731 $335,000
Q2 2022

Aug 15, 2022
SELL
$0.51 - $2.42 $297,061 - $1.41 Million
-582,473 Reduced 74.44%
200,000 $120,000
Q1 2022

May 16, 2022
BUY
$2.45 - $5.04 $1.92 Million - $3.94 Million
782,473 New
782,473 $1.92 Million

Others Institutions Holding NRXP

# of Institutions
2
Shares Held
17.4K
Call Options Held
0
Put Options Held
0
View Full List

About NRX Pharmaceuticals, Inc.

NRXP Quotes by TradingView
  • Ticker NRXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,641,296
  • Market Cap $111M
  • Description
  • NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...
More about NRXP
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email